Classic Congenital Adrenal Hyperplasia clinical trials at UCSF

1 research study open to eligible people

Classic congenital adrenal hyperplasia is a birth disorder that disrupts adrenal hormone production. UCSF is testing a new oral medicine in children and checking how the body breaks it down. UCSF is recording safety results and drug levels in the blood.

Showing trials for

  • Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)

    open to eligible people ages 1-17

    The purpose of this study is to evaluate the safety, efficacy, pharmacokinetics (PK), and pharmacodynamics (PD) of atumelnant treatment in pediatric participants with classic congenital adrenal hyperplasia (CAH).

    San Francisco, California and other locations

Last updated: